Aditi Kulkarni

4PUBLICATIONS
73CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 15, 2026
Tim-3 Sustains Tumor Treg Stability and Function, Limiting Checkpoint Blockade Therapy Efficacy.

|Jun 25, 2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

|Apr 01, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Sri Vemulamanda, Aditi Kothari, Loris De Cecco

|Mar 05, 2026
Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors.

Huaibin Ge, Housaiyin Li, Aditi Kulkarni

Pageof 1

Frequent Collaborators

4 joint publications

Pragati Upadhyay

4 joint publications

Robert L Ferris

2 joint publications

Housaiyin Li

1 joint publications

Huaibin Ge